Zakrzewski Joseph S
SEC CIK 1331852 · EDGAR
BoughtSold
Most active insiders at ANTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Readnour Robin Shane | Dir | — | $316.7K |
| 2 | Eizen Joshua M | See Remarks | — | $52.9K |
| 3 | FitzPatrick Margaret M | Dir | $11.6K | — |
| 4 | Chanda Sanjay | Chief Development Off | — | $9,311 |
| 5 | Day Lucy | CFO | — | $8,862 |
| 6 | Prior Stephen David | Chief Strategy Off | — | $7,363 |
| 7 | Williams Sarah Joanne | Principal Accounting Off | — | $3,025 |
| 8 | Trenor Cameron C. III | Chief Medical Off | — | — |
| 9 | Marks Gilbert Lynn | Dir | — | — |
| 10 | Martin Patricia A. | Dir | — | — |
| 13 | Zakrzewski Joseph S | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-14 14:12 | 2026-08-14 | ANTX | AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Dir | G - Gift | $0.00 | -405.9K | 0 | -100% | $0 |
| 2025-04-11 | 2025-04-10 | ANTX | AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Dir | A - Grant | $0.00 | +10.5K | 145.5K | +8% | $0 | |
| 2024-12-23 | 2024-12-19 | ANTX | AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Dir | A - Grant | $0.00 | +9,816 | 135.0K | +8% | $0 | |
| 2024-11-27 | 2024-11-27 | ANTX | AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Dir | P - Purchase | $1.40 | +2,000 | 125.2K | +2% | +$2,800 | |
| M | 2024-11-20 | 2024-11-18+ | ANTX | AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Dir | P - Purchase | $1.00 | +25.0K | 118.2K | +27% | +$25.1K |
| I | 2024-01-19 | 2024-01-18 | ANTX | AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Dir | S - Sale | $19.11 | -100.0K | 405.9K | -20% | -$1.91M |
| D | 2022-03-31 | 2022-03-29 | ANTX | AN2 Therapeutics, Inc. | Zakrzewski Joseph S | Dir | C - Cnv Deriv | — | +98.2K | 98.2K | New | — |
| M | 2021-12-16 | 2021-12-14+ | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Dir | P - Purchase | $3.25 | +12.0K | 196.5K | +7% | +$39.0K |
Purchase Sale Sale after option exercise All abbreviations